LOLLI, C.; VERDE, A.; DEGLI ESPOSTI, L.; ACCIAI, V.; BRIGIDO, A.; PROIETTI, E.; SCAGLIARINI, S. Cabozantinib use in second or subsequent line of treatment in renal cell carcinoma: an analysis of Italian administrative databases. Global and Regional Health Technology Assessment, [S. l.], v. 11, n. 1, p. 154–160, 2024. DOI: 10.33393/grhta.2024.2892. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/2892. Acesso em: 27 jul. 2024.